{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:11:10Z","timestamp":1791159070953,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["20390297"],"award-info":[{"award-number":["20390297"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","award":["AS232Z00009G"],"award-info":[{"award-number":["AS232Z00009G"]}],"id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["H17-Kokoro-019"],"award-info":[{"award-number":["H17-Kokoro-019"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["H20-Kokoro-022"],"award-info":[{"award-number":["H20-Kokoro-022"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["H22-Nanji-Ippan-002"],"award-info":[{"award-number":["H22-Nanji-Ippan-002"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["brainanddevelopment.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain and Development"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.braindev.2012.05.008","type":"journal-article","created":{"date-parts":[[2012,6,7]],"date-time":"2012-06-07T14:30:47Z","timestamp":1339079447000},"page":"317-322","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":89,"title":["The chaperone activity and toxicity of ambroxol on Gaucher cells and normal mice"],"prefix":"10.1016","volume":"35","author":[{"given":"Zhuo","family":"Luan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linjing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsumi","family":"Higaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiji","family":"Nanba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyuki","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kousaku","family":"Ohno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.braindev.2012.05.008_b0005","series-title":"The metabolic and molecular bases of inherited disease","first-page":"3635","article-title":"Gaucher disease","author":"Beutler","year":"2001"},{"key":"10.1016\/j.braindev.2012.05.008_b0010","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.cbpa.2007.05.035","article-title":"Gaucher disease","volume":"11","author":"Butters","year":"2007","journal-title":"Curr Opin Chem Biol"},{"key":"10.1016\/j.braindev.2012.05.008_b0015","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJM199105233242104","article-title":"Replacement therapy for inherited enzyme deficiency-macrophage-targeted glucocerebrosidase for Gaucher\u2019s disease","volume":"324","author":"Barton","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.braindev.2012.05.008_b0020","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/S0140-6736(00)02161-9","article-title":"Novel oral treatment of Gaucher\u2019s disease with N-butyldeoxynojirimycin(OGT918) to decrease substrate biosynthesis","volume":"355","author":"Cox","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.braindev.2012.05.008_b0025","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0268-960X(98)90023-6","article-title":"Enzyme therapy for Gaucher disease: the first 5 years","volume":"12","author":"Grabowski","year":"1998","journal-title":"Blood Rev"},{"key":"10.1016\/j.braindev.2012.05.008_b0030","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1023\/A:1010335505357","article-title":"Inhibition of substrate synthesis as a strategy for glycolipids lysosomal storage disease therapy","volume":"24","author":"Platt","year":"2001","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.braindev.2012.05.008_b0035","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/ana.410420412","article-title":"Prospective study of neurological responses to treatment with macrophage-targeted glucocerebrosidase in patients with type 3 Gaucher\u2019s disease","volume":"42","author":"Schiffmann","year":"1997","journal-title":"Ann Neurol"},{"key":"10.1016\/j.braindev.2012.05.008_b0040","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/(SICI)1096-8628(19970711)71:1<16::AID-AJMG3>3.0.CO;2-O","article-title":"Gaucher disease: enzyme therapy in the acute neuronopathic variant","volume":"71","author":"Prows","year":"1997","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.braindev.2012.05.008_b0045","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s004310000630","article-title":"Improvement of neurological symptoms by enzyme replacement therapy for Gaucher disease type IIIb","volume":"160","author":"Aoki","year":"2001","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.braindev.2012.05.008_b0050","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s10545-006-0272-5","article-title":"Substrate reduction therapy of glycosphingolipid storage disorders","volume":"29","author":"Aerts","year":"2006","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.braindev.2012.05.008_b0055","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1093\/hmg\/ddi240","article-title":"ER retention and degradation as the molecular basis underlying Gaucher disease heterogeneity","volume":"14","author":"Ron","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.braindev.2012.05.008_b0060","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/0960-894X(96)00146-1","article-title":"Synthesis of potent \u03b2-D-glucocerebrosidase inhibitors: N-alkyl-\u03b2-valienamines","volume":"6","author":"Ogawa","year":"1996","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.braindev.2012.05.008_b0065","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.bbadis.2004.03.007","article-title":"N-Octyl-\u03b2-valienamine upregulates activity of F213I mutant \u03b2-glucosidase in cultured cells: a potential chemical chaperone therapy for Gaucher disease","volume":"1689","author":"Lin","year":"2004","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.braindev.2012.05.008_b0070","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.bbadis.2007.02.003","article-title":"Enzyme enhancement activity of N-octyl-\u03b2-valienamine on \u03b2-glucosidase mutants associated with Gaucher disease","volume":"1772","author":"Lei","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.braindev.2012.05.008_b0075","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1002\/cbic.200900442","article-title":"Chaperone activity of bicyclic nojirimycin analogues for Gaucher mutations in comparison with N-(n-nonyl)deoxynojirimycin","volume":"10","author":"Luan","year":"2009","journal-title":"ChemBiochem"},{"key":"10.1016\/j.braindev.2012.05.008_b0080","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.bcmd.2009.10.003","article-title":"The pharmacological chaperone effect of N-octyl-\u03b2-valienamine on human mutant acid \u03b2-glucosidases","volume":"44","author":"Luan","year":"2010","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.braindev.2012.05.008_b0085","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.braindev.2009.12.005","article-title":"The effect of N-octyl-\u03b2-valienamine on \u03b2-glucosidase activity in tissues of normal mice","volume":"32","author":"Luan","year":"2010","journal-title":"Brain Dev"},{"key":"10.1016\/j.braindev.2012.05.008_b0090","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1002\/cbic.201000323","article-title":"A Fluorescent sp2-iminosugar with pharmacological chaperone activity for Gaucher disease: synthesis and intracellular distribution studies","volume":"11","author":"Luan","year":"2010","journal-title":"ChemBiochem"},{"key":"10.1016\/j.braindev.2012.05.008_b0095","doi-asserted-by":"crossref","first-page":"23502","DOI":"10.1074\/jbc.M109.012393","article-title":"Identification and characterization of ambroxol as an enzyme enhancement agent for Gaucher disease","volume":"284","author":"Maegawa","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.braindev.2012.05.008_b0100","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.chembiol.2005.09.007","article-title":"Gaucher disease-associated glucocerebrosidases show mutation-dependent chemical chaperoning profiles","volume":"12","author":"Sawkar","year":"2005","journal-title":"Chem Biol"},{"key":"10.1016\/j.braindev.2012.05.008_b0105","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/labinvest.3700305","article-title":"Helicobacter felis-induced gastritis was suppressed in mice overexpressing thioredoxin-1","volume":"85","author":"Kawasaki","year":"2005","journal-title":"Lab Invest"},{"key":"10.1016\/j.braindev.2012.05.008_b0110","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/0009-9120(87)90010-5","article-title":"Effect of a heat-stable factor in human placenta on glucosylceramidase, glucosylsphingosine glucosyl hydrolase, and acid \u03b2-glucosidase activities","volume":"20","author":"Vaccaro","year":"1987","journal-title":"Clin Biochem"},{"key":"10.1016\/j.braindev.2012.05.008_b0115","doi-asserted-by":"crossref","first-page":"15428","DOI":"10.1073\/pnas.192582899","article-title":"Chemical chaperones increase the cellular activity of N370S \u03b2-glucosidase: a therapeutic strategy for Gaucher disease","volume":"99","author":"Sawkar","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.braindev.2012.05.008_b0120","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1023\/B:BOLI.0000042959.44318.7c","article-title":"Correlation between enzyme activity and substrate storage in a cell culture model system for Gaucher disease","volume":"27","author":"Schueler","year":"2004","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.braindev.2012.05.008_b0125","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/BF03401556","article-title":"Failure of alglucerase infused into Gaucher disease patients to localize in marrow macrophages","volume":"1","author":"Beutler","year":"1995","journal-title":"Mol Med"},{"key":"10.1016\/j.braindev.2012.05.008_b0130","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/BF00271364","article-title":"Dose-dependent uricosuric effect of ambroxol","volume":"44","author":"Oosterhuis","year":"1993","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.braindev.2012.05.008_b0135","doi-asserted-by":"crossref","first-page":"e19037","DOI":"10.1371\/journal.pone.0019037","article-title":"Isofagomine in vivo effects in a neuronopathic Gaucher disease mouse","volume":"6","author":"Sun","year":"2011","journal-title":"PLoS One"}],"container-title":["Brain and Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S038776041200126X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S038776041200126X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T19:47:29Z","timestamp":1759952849000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S038776041200126X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S038776041200126X"],"URL":"https:\/\/doi.org\/10.1016\/j.braindev.2012.05.008","relation":{},"ISSN":["0387-7604"],"issn-type":[{"value":"0387-7604","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The chaperone activity and toxicity of ambroxol on Gaucher cells and normal mice","name":"articletitle","label":"Article Title"},{"value":"Brain and Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.braindev.2012.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}